Initial Triple Combination Therapy Including Intravenous Prostaglandin I2 for the Treatment of Patients with Severe Pulmonary Arterial Hypertension
International Heart Journal · 2023
DOI: 10.1536/ihj.23-047 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Heart Journal, 2023. Verfasst von Yuichi Tamura und 10 weiteren Autor:innen. Beteiligte Einrichtung: Pulmonary Hypertension Center, International University of Health and Welfare Mita Hospital. Hauptthemen laut MEDLINE: Epoprostenol, Pulmonary Arterial Hypertension, Antihypertensive Agents, Hypertension, Pulmonary. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 27 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Pulmonary Hypertension Center, International University of Health and Welfare Mita Hospital.
- Japan Pulmonary Hypertension Registry (JAPHR) Network.
- Department of Healthcare Quality Assessment, Graduate School of Medicine, The University of Tokyo.
- Medical Division, GSK K.K.
- National Hospital Organization Okayama Medical Center.
- Division of Cardiovascular Medicine, Department of Internal Medicine, Kobe University Graduate School of Medicine.
Zitieren
APA
Tamura, Y., Kumamaru, H., Nishimura, S., Nakajima, Y., Matsubara, H., Taniguchi, Y., Tsujino, I., Shigeta, A., Kinugawa, K., Kimura, K., & Tatsumi, K. (2023). Initial Triple Combination Therapy Including Intravenous Prostaglandin I2 for the Treatment of Patients with Severe Pulmonary Arterial Hypertension. International Heart Journal. https://doi.org/10.1536/ihj.23-047
Vancouver
Tamura Y, Kumamaru H, Nishimura S, Nakajima Y, Matsubara H, Taniguchi Y, et al. Initial Triple Combination Therapy Including Intravenous Prostaglandin I2 for the Treatment of Patients with Severe Pulmonary Arterial Hypertension. International Heart Journal. 2023. doi:10.1536/ihj.23-047
BibTeX
@article{Tamura2023,
author = {Tamura, Yuichi and Kumamaru, Hiraku and Nishimura, Shiori and Nakajima, Yasuo and Matsubara, Hiromi and Taniguchi, Yu and Tsujino, Ichizo and Shigeta, Ayako and Kinugawa, Koichiro and Kimura, Kazuhiro and Tatsumi, Koichiro},
title = {Initial Triple Combination Therapy Including Intravenous Prostaglandin I2 for the Treatment of Patients with Severe Pulmonary Arterial Hypertension},
journal = {International Heart Journal},
year = {2023},
doi = {10.1536/ihj.23-047}
}
EUVIMED